在泰国青少年中,与药物坚持相关的背景因素与严重抑郁症相关
Suchanart Inwanna1, Alicia K Matthews2, Cynthia Taylor Handrup3
1Ramathibodi School of Nursing, Faculty of Medicine Ramathibodi Hospital, Mahidol University, Bangkok, Thailand.
Patient preference and adherence
|December 3, 2025
概括
泰国青少年患有严重抑郁症 (MDD) 的药物坚持率较低. 坚持与青少年和监护人的抗抑郁药副作用和治疗偏好有关,突出了对个性化护理的需求.
科学领域:
- 青少年精神病学 青少年精神病学
- 心理健康研究 心理健康研究
- 药理学坚持性研究研究药理学坚持性研究.
背景情况:
- 大型抑郁症 (MDD) 在全球范围内显著影响青少年.
- 低剂量药物坚持是泰国青少年患有MDD的一个关键问题.
- 泰国的文化因素需要对守的特定背景研究.
研究的目的:
- 探索影响泰国青少年MDD药物坚持的特定背景因素.
- 应用个人和家庭自我管理理论 (IFSMT) 来理解坚持的决定因素.
- 为了确定独特的文化和社会影响在治疗坚持.
主要方法:
- 涉及泰国146名青少年法定监护人二元组的横截面定量研究.
- 从精神病诊所进行有目的的抽样.
- 多重线性回归分析以评估IFSMT上下文因素和坚持之间的关联.
主要成果:
- 大约80%的青少年报告说,他们对药物的坚持很低.
- 坚持治疗的重要预测因素包括抗抑郁药的副作用,以及青少年/监护人对仅用药治疗的偏好.
- 其他评估的上下文因素没有显示出与坚持的显著关联.
结论:
- 泰国青少年患有MDD的坚持受到患者和监护人的副作用和治疗偏好的影响.
- 将个人和家庭的偏好纳入治疗规划是改善治疗坚持的关键.
- 建议采取文化敏感的干预措施,以提高药物坚持的结果.
相关概念视频
Drug Therapy
232
The advent of drug therapy has profoundly shaped modern mental health care, providing targeted treatments for a range of psychological disorders. Psychotherapeutic drugs, classified into antianxiety, antidepressant, and antipsychotic medications, address symptoms across anxiety disorders, mood disorders, and schizophrenia. While these medications have transformed patient outcomes, they require careful management due to their potential side effects and limitations.
Antianxiety Medications
Antianxiety Medications
232
Depressive Disorders: Etiology
415
Depressive disorders result from a complex interplay of biological, psychological, and sociocultural factors, each contributing uniquely to the development and persistence of the condition. Understanding these factors provides critical insight into the multifaceted nature of depression.
Biological Factors in Depression
Biological predispositions significantly influence the risk of developing depressive disorders. Genetic studies highlight the role of variations in the serotonin transporter...
Biological Factors in Depression
Biological predispositions significantly influence the risk of developing depressive disorders. Genetic studies highlight the role of variations in the serotonin transporter...
415
Therapeutic Drug Monitoring: Affecting Factors
182
Therapeutic Drug Monitoring (TDM) is the clinical practice of measuring specific drug levels in a patient's blood or body tissues to manage and optimize therapy. TDM is crucial for drugs with narrow therapeutic windows, like warfarin and phenytoin, where incorrect doses can lead to treatment failure or severe side effects. This monitoring ensures the dosage administered is within a safe and effective range. The factors affecting therapeutic drug monitoring include:Patient-Specific Factors:a.
182
Attention-Deficit/Hyperactivity Disorder
718
Attention-deficit/hyperactivity disorder (ADHD) is a neurodevelopmental disorder characterized by persistent inattention, hyperactivity, and impulsivity. It affects approximately 5-8% of children globally, with around 60-70% of cases persisting into adulthood. ADHD has significant implications for educational attainment, social interactions, and occupational success.
Diagnostic Criteria and Symptoms
To diagnose ADHD, symptoms must manifest before age 12 and be evident across multiple settings....
Diagnostic Criteria and Symptoms
To diagnose ADHD, symptoms must manifest before age 12 and be evident across multiple settings....
718
Antidepressant Drugs: MAOIs and Other Agents
774
Atypical antidepressants, including bupropion (Wellbutrin), mirtazapine (Remeron), nefazodone (Serzone), trazodone (Desyrel), and vilazodone (Viibryd), offer unique mechanisms of action. Bupropion weakly inhibits dopamine and norepinephrine reuptake, aiding depression treatment and smoking cessation, with a low risk of sexual dysfunction. Mirtazapine enhances serotonin and norepinephrine neurotransmission, leading to sedation, increased appetite, and weight gain. As a result, it helps treat...
774
Depression: Overview
750
Depression is a prevalent mental illness marked by persistent sadness and lack of interest in previously enjoyable activities. It can take several forms, including major depression, persistent depressive disorder, and bipolar I and II disorders. Symptoms range from emotional changes like chronic worry to physical changes like sleep disturbances and suicidal thoughts. From a neurobiological perspective, depression is believed to be triggered by abnormalities in the brain's prefrontal cortex,...
750


